IPOs Are Back: Liquid Biopsy, Cardio, Dialysis Firms Lead $1.5Bn Charge
Executive Summary
Who wants to go public during a once-in-a-century crisis? It seems like quite a few medtechs do.
You may also be interested in...
Medtronic Cardiovascular Chief Coyle To Lead iRhythm
Sean Salmon, the head of Medtronic’s diabetes business, will take over the leadership of the company’s cardiovascular business effective 1 January.
Medical Imaging Disruptor Nano-X Pushes On With Launch Plans In Face Of Shareholder Lawsuit
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
Renalytix AI Launches Trial To Identify COVID-19 Patients With Kidney Injury
The Mount Sinai spin-off believes its KindeyIntelX system can identify COVID-19 patients at high risk for long-term kidney damage.